Pharmaceutical and cosmetics giant Johnson & Johnson is facing three more asbestos cancer lawsuit trials across the country over allegations that the company’s talcum-based products caused various types of cancers developed by the plaintiffs. Johnson & Johnson and its talc supplier, Imerys Talc USA, have recently lost a series of trials in which juries handed down substantial verdicts in favor of plaintiffs to compensate the victims for their mesothelioma cancer diagnoses.
In California, attorneys for both sides will soon give their closing arguments in an asbestos talcum powder cancer trial in a Los Angeles Superior Court room. In that case, the plaintiffs represent the estate of the cancer victim who allegedly passed away from a mesothelioma diagnosis brought on by years of using talcum powder products produced by Johnson & Johnson and sourced with materials from Imerys.
In South Carolina, Johnson & Johnson will soon give its opening statements in a talcum powder asbestos cancer lawsuit and will do the same a week later in a Middlesex County Superior Court in New Jersey. Those two upcoming trials also allege that Johnson & Johnson and talc supplier Imerys Talc USA knowingly produced and sold talcum powder products contaminated with asbestos fibers.